Can mobile phlebotomy reduce infection risk?

Yes. Avoiding clinical waiting rooms reduces patients' exposure to other illnesses — especially valuable for immunocompromised individuals.

Cancer patients on chemotherapy, transplant recipients, and patients with autoimmune conditions face meaningful risk in a lab waiting room. Home blood draws eliminate this exposure entirely, which is why oncologists, transplant centers, and infectious disease specialists increasingly recommend mobile phlebotomy for vulnerable patients.